These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34817233)

  • 1.
    Lee B; Yan J; Ulhaq A; Miller S; Seo W; Lu P; She R; Spellberg B; Luna B
    mSphere; 2021 Dec; 6(6):e0092021. PubMed ID: 34817233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.
    Urban C; Mariano N; Rahal JJ
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2732-4. PubMed ID: 20368401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
    Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
    Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Distribution and Drug Resistance Characteristics of Pathogenic Bacteria in the Elderly Population in China in 2021].
    Tang S; Xiao Y; Li J; Li D; Wu S; Huang X; Li J; Yang L; Li J; Wang T; Zhang G; Xu Y; Xie Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jul; 55(4):989-994. PubMed ID: 39170001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii.
    Garza-González E; Llaca-Díaz JM; Bosques-Padilla FJ; González GM
    Chemotherapy; 2010; 56(4):275-9. PubMed ID: 20693798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of antimicrobial susceptibility among bacterial isolates from intensive care unit patients of a tertiary-care university hospital in Iran: 2006-2009.
    Mohammadtaheri Z; Pourpaki M; Mohammadi F; Namdar R; Masjedi MR
    Chemotherapy; 2010; 56(6):478-84. PubMed ID: 21099220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
    Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
    Hamouche E; Sarkis DK
    Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic resistance in gram-negative bacilli: a Singapore perspective.
    Tan TY; Hsu LY; Koh TH; Ng LS; Tee NW; Krishnan P; Lin RT; Jureen R
    Ann Acad Med Singap; 2008 Oct; 37(10):819-25. PubMed ID: 19037514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current trends in antimicrobial resistance of ESKAPEEc pathogens from bloodstream infections - Experience of a tertiary care centre in North India.
    Gupta M; Gupta V; Gupta R; Chaudhary J
    Indian J Med Microbiol; 2024; 50():100647. PubMed ID: 38871082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of biocide resistant genes and biocides susceptibility in multidrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii - A first report from the Kingdom of Saudi Arabia.
    Vijayakumar R; Sandle T; Al-Aboody MS; AlFonaisan MK; Alturaiki W; Mickymaray S; Premanathan M; Alsagaby SA
    J Infect Public Health; 2018; 11(6):812-816. PubMed ID: 29907439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms.
    Chang PC; Chen CC; Lu YC; Lai CC; Huang HL; Chuang YC; Tang HJ
    J Microbiol Immunol Infect; 2018 Apr; 51(2):207-213. PubMed ID: 29037802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic resistance in clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus does not impact sensitivity to human beta defensin 4.
    Supp DM; Gardner J; Klingenberg JM; Neely AN
    Burns; 2009 Nov; 35(7):949-55. PubMed ID: 19501982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program.
    Diekema DJ; Hsueh PR; Mendes RE; Pfaller MA; Rolston KV; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro Activity of Sitafloxacin and Other Antibiotics against Bacterial Isolates from HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University and Samitivej Sukhumvit Hospital.
    Tantisiriwat W; Linasmita P
    J Med Assoc Thai; 2017 Apr; 100(4):469-78. PubMed ID: 29912484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of escherichia coli, klebsiella pneumoniae, acinetobacter baumannii and pseudomonas aeruginosa from the MYSTIC surveillance program: the OPTAMA Program, South America 2002.
    Kiffer CR; Mendes C; Kuti JL; Nicolau DP
    Diagn Microbiol Infect Dis; 2004 Jun; 49(2):109-16. PubMed ID: 15183860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
    Zhang X; Gu B; Mei Y; Wen Y; Xia W
    J Antibiot (Tokyo); 2015 Feb; 68(2):115-20. PubMed ID: 25182483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
    Balkhair A; Al-Muharrmi Z; Al'Adawi B; Al Busaidi I; Taher HB; Al-Siyabi T; Al Amin M; Hassan KS
    Int J Infect Dis; 2019 Aug; 85():10-15. PubMed ID: 31100418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.